首页> 外国专利> Pharmaceutical compositions for colon-specific delivery

Pharmaceutical compositions for colon-specific delivery

机译:用于结肠特异性递送的药物组合物

摘要

Disclosed are pharmaceutical particulates which release a pharmaceutical compound into the colon following oral administration. A particulate comprises a core comprising a pharmaceutical compound, an inner coating surrounding the core, wherein the inner coating comprises a pharmaceutically acceptable polysaccharide that is susceptible to enzymatic digestion by one or more enzymes present colonic microflora, and an outer coating surrounding the inner coating, wherein the outer coating comprises a polymer which is stable at upper gastrointestinal pH but can dissolve at pH6. The core of a particulate can further comprise an excipient such as a diluent, a binder, a disintegrant, a lubricant, a glidant or a combination thereof. Particulates can comprise pharmaceutical compounds for treating colonic diseases such as C. difficile infection, ulcerative colitis, colon cancer, and Crohn's disease.
机译:公开了在口服给药后将药物化合物释放到结肠中的药物颗粒。微粒包括:包含药物化合物的芯;围绕该芯的内涂层,其中该内涂层包含易于被存在于结肠菌群中的一种或多种酶进行酶消化的药学上可接受的多糖,以及围绕该内涂层的外涂层,其中外涂层包含在较高胃肠道pH下稳定但可在pH> 6下溶解的聚合物。颗粒的核可进一步包含赋形剂,例如稀释剂,粘合剂,崩解剂,润滑剂,助流剂或其组合。颗粒可以包含用于治疗结肠疾病例如I C的药物化合物。困难感染,溃疡性结肠炎,结肠癌和克罗恩氏病。

著录项

  • 公开/公告号US10588864B2

    专利类型

  • 公开/公告日2020-03-17

    原文格式PDF

  • 申请/专利权人 GATEWAY PHARMACEUTICAL LLC;

    申请/专利号US201715703172

  • 发明设计人 LIANLI LI;

    申请日2017-09-13

  • 分类号A61K9/48;A61K9/20;A61K9/28;A61K31/4164;A61K9;

  • 国家 US

  • 入库时间 2022-08-21 11:30:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号